Persistent lung and arterial inflammation following COVID-19 pneumonia

Not Applicable

• Conditions: Pneumonia; COVID-19; Infection - Other infectious diseases; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12620000778987
• Lead Sponsor: Sir Charles Gairdner Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-30
• Last Update Posted: 3 August 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

· Both males and females aged 50 years or greater.
· At minimum of 30 days and no more than 45 days post COVID-19 pneumonia diagnosis.
· Recovered as defined by nasal or oropharyngeal swab confirmed as negative for SARSCoV-
2 in the recovery phase of their illness.
· Evidence of pulmonary infiltrates on chest x-ray or Chest CT (multilobar, interstitial or
ground glass opacities) suggestive of pneumonia during index admission.
· Able to provide informed consent and undergo study procedures

Exclusion Criteria

· Clinically unstable patients considered unsuitable for 18FDG-PET/CT test
· COVID-19 status unknown at the time of enrolment.
· People with poorly controlled diabetes
· People with known immuno-deficiency or active malignancy.

Study & Design

• Study Type: Observational
• Study Design: Not specified